1. Home
  2. NURO vs GRNQ Comparison

NURO vs GRNQ Comparison

Compare NURO & GRNQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NURO
  • GRNQ
  • Stock Information
  • Founded
  • NURO 1996
  • GRNQ 2013
  • Country
  • NURO United States
  • GRNQ Malaysia
  • Employees
  • NURO N/A
  • GRNQ N/A
  • Industry
  • NURO Medical/Dental Instruments
  • GRNQ EDP Services
  • Sector
  • NURO Health Care
  • GRNQ Technology
  • Exchange
  • NURO Nasdaq
  • GRNQ Nasdaq
  • Market Cap
  • NURO 8.2M
  • GRNQ 8.9M
  • IPO Year
  • NURO N/A
  • GRNQ 2018
  • Fundamental
  • Price
  • NURO $4.37
  • GRNQ $1.10
  • Analyst Decision
  • NURO
  • GRNQ
  • Analyst Count
  • NURO 0
  • GRNQ 0
  • Target Price
  • NURO N/A
  • GRNQ N/A
  • AVG Volume (30 Days)
  • NURO 21.7K
  • GRNQ 217.8K
  • Earning Date
  • NURO 02-20-2025
  • GRNQ 03-27-2025
  • Dividend Yield
  • NURO N/A
  • GRNQ N/A
  • EPS Growth
  • NURO N/A
  • GRNQ N/A
  • EPS
  • NURO N/A
  • GRNQ N/A
  • Revenue
  • NURO $3,767,764.00
  • GRNQ $2,727,344.00
  • Revenue This Year
  • NURO N/A
  • GRNQ N/A
  • Revenue Next Year
  • NURO N/A
  • GRNQ N/A
  • P/E Ratio
  • NURO N/A
  • GRNQ N/A
  • Revenue Growth
  • NURO N/A
  • GRNQ N/A
  • 52 Week Low
  • NURO $2.66
  • GRNQ $0.80
  • 52 Week High
  • NURO $4.73
  • GRNQ $2.24
  • Technical
  • Relative Strength Index (RSI)
  • NURO 67.97
  • GRNQ 51.38
  • Support Level
  • NURO $4.16
  • GRNQ $0.97
  • Resistance Level
  • NURO $4.40
  • GRNQ $1.28
  • Average True Range (ATR)
  • NURO 0.09
  • GRNQ 0.06
  • MACD
  • NURO 0.03
  • GRNQ 0.00
  • Stochastic Oscillator
  • NURO 95.24
  • GRNQ 73.91

About NURO NeuroMetrix Inc.

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management, cross-border listing advisory services, and transaction services. It also operates a venture capital business. Its segments include Service business engaged in the provision of corporate advisory and business solution services; and Real estate business engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia.

Share on Social Networks: